ARCHIVES

Jordan Gutterman Selected To Head Lasker Awards Program

This article is from The Cancer Letter archive.

Vol. 17 No. 01 | January 4, 1991

Download PDF Visit The Full Archive

Related Articles

SSO Education Group Lists “Major Unmet Needs, Problems”

November 25, 1983

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response

July 29, 2011

New NCAB Task Force On Clinical Trials Is Attempt To Bring NCI, Groups Together

June 3, 1994

In Brief: Goldman Named Director, Albert Einstein Cancer Center; Wiernik Resumes Post

October 20, 1995

No Benefit To Kidney Removal For Elderly With Kidney Cancer

May 28, 2010